News & Articles blepharitis InSite Vision Announces Top-line Results from the DOUBle Phase 3 Clinical Study for the Treatment of Moderate-to ... InSite Vision Incorporated today announced top-line clinical results from the DOUBle Phase 3 clinical trial of AzaSite Plus™ and DexaSite™ for the treatment of moderate-to-severe blepharitis. July 23, 2013 - Business Wire via Yahoo! Finance